| Date Filed | Type | Description |
| 06/05/2019 |
4
| PFEFFER MATTHEW J (Director) has filed a Form 4 on SECOND SIGHT MEDICAL PRODUCTS INC|
Txns:
| Granted 56,685 options to buy
@ $0.7088, valued at
$40.2k
|
|
| 06/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2017 |
4
| PFEFFER MATTHEW J (Director) has filed a Form 4 on SECOND SIGHT MEDICAL PRODUCTS INC|
Txns:
| Granted 59,725 shares
@ $1.172, valued at
$70k
|
|
| 03/16/2017 |
4
| PFEFFER MATTHEW J (Director) has filed a Form 4 on SECOND SIGHT MEDICAL PRODUCTS INC |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/16/2016 |
4
| PFEFFER MATTHEW J (CEO, CFO, Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 25,000 shares
@ $0.986, valued at
$24.7k
|
|
| 06/03/2016 |
4
| PFEFFER MATTHEW J (Director) has filed a Form 4 on SECOND SIGHT MEDICAL PRODUCTS INC|
Txns:
| Granted 17,461 shares
@ $3.9515, valued at
$69k
|
|
| 02/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/03/2015 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Paid exercise price by delivering 1,598 shares
@ $4.09, valued at
$6.5k
Paid exercise price by delivering 1,598 shares
@ $4.15, valued at
$6.6k
Paid exercise price by delivering 912 shares
@ $3.79, valued at
$3.5k
Paid exercise price by delivering 846 shares
@ $3.79, valued at
$3.2k
Granted 16,100 shares
@ $0
Granted 72,300 options to buy
@ $3.91, valued at
$282.7k
|
|
| 02/25/2015 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 15,000 shares
@ $0
Paid exercise price by delivering 5,975 shares
@ $6.43, valued at
$38.4k
Exercised 60,000 options to buy
@ $2.86, valued at
$171.6k
|
|
| 08/26/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 220,000 shares
@ $0
Paid exercise price by delivering 114,796 shares
@ $8.53, valued at
$979.2k
Granted 9,700 shares
@ $0
Paid exercise price by delivering 1,175 shares
@ $7.09, valued at
$8.3k
Granted 60,000 options to buy
@ $1.69, valued at
$101.4k
Granted 180,000 options to buy
@ $6.85, valued at
$1.2M
Granted 43,400 options to buy
@ $7.09, valued at
$307.7k
|
|
| 08/19/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Paid exercise price by delivering 2,218 shares
@ $6.86, valued at
$15.2k
Paid exercise price by delivering 2,218 shares
@ $6.86, valued at
$15.2k
Paid exercise price by delivering 1,696 shares
@ $7.23, valued at
$12.3k
|
|
| 07/17/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 229,000 shares
@ $0
Paid exercise price by delivering 109,456 shares
@ $10, valued at
$1.1M
Granted 60,000 options to buy
@ $1.69, valued at
$101.4k
Granted 90,000 options to buy
@ $6.85, valued at
$616.5k
Granted 36,000 options to buy
@ $2.86, valued at
$103k
Granted 80,000 options to buy
@ $1.69, valued at
$135.2k
Granted 180,000 options to buy
@ $6.85, valued at
$1.2M
|
|
| 07/03/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Sold 20,000 shares
@ $10.4384, valued at
$208.8k
|
|
| 06/30/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 527 shares
@ $4.42, valued at
$2.3k
|
|
| 06/06/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Sold 10,000 shares
@ $10, valued at
$100k
Granted 10,000 shares
@ $2.23, valued at
$22.3k
Disposed/sold 10,000 shares
@ $11, valued at
$110k
Exercised 10,000 options to buy
@ $2.23, valued at
$22.3k
|
|
| 04/03/2014 |
4
| PFEFFER MATTHEW J (Director) has filed a Form 4 on DS HEALTHCARE GROUP, INC.|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 02/18/2014 |
4/A
| PFEFFER MATTHEW J (Director) has filed a Form 4 on DS HEALTHCARE GROUP, INC.|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 01/03/2014 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 487 shares
@ $4.53, valued at
$2.2k
|
|
| 11/27/2013 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 110,000 shares
@ $0
Paid exercise price by delivering 41,338 shares
@ $4.88, valued at
$201.7k
|
|
| 08/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2013 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Sold 10,000 shares
@ $8, valued at
$80k
Exercised 10,000 options to buy
@ $2.86, valued at
$28.6k
|
|
| 01/03/2013 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 1,056 shares
@ $1.95, valued at
$2.1k
|
|
| 11/28/2012 |
4
| PFEFFER MATTHEW J (Director) has filed a Form 4 on Divine Skin Inc. |
| 11/28/2012 |
3
| PFEFFER MATTHEW J (Director) has filed a Form 3 on Divine Skin Inc. |
| 08/21/2012 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 17,000 shares
@ $0
Granted 72,000 options to buy
@ $2.32, valued at
$167k
|
|
| 07/03/2012 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 1,054 shares
@ $1.95, valued at
$2.1k
|
|
| 05/21/2012 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 200,000 options to buy
@ $1.69, valued at
$338k
|
|
| 08/19/2011 |
4
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 17,000 shares
@ $0
Granted 73,500 options to buy
@ $2.41, valued at
$177.1k
|
|
| 03/31/2011 |
5/A
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 5/A on MANNKIND CORP |
| 03/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|